Prokidney Corp (PROK)

03:26 AM

ProKidney Stock Skyrockets But Greensboro Is Still Empty Handed - Rhino Times

03:26 AM

03:10 AM

What analysts say about ProKidney Corp. stockUnmatched profit potential - PrintWeekIndia

03:10 AM

04:55 AM

Is ProKidney Corp. a good long term investmentFree Capital Allocation Plans - PrintWeekIndia

04:55 AM

04:02 AM

Published on: 2025-07-25 13:32:55 - PrintWeekIndia

04:02 AM

Jul 24, 2025

Meet the Biotech Stock That Rocketed 775% Higher - AOL.com

Jul 24, 2025

Jul 24, 2025

Prokidney’s REACT Study: A Promising Step for Kidney Disease Treatment - TipRanks

Jul 24, 2025

Jul 23, 2025

What drives ProKidney Corp. stock priceHigh-octane financial growth - Autocar Professional

Jul 23, 2025

Jul 23, 2025

BlackRock, Inc. Reduces Stake in ProKidney Corp: A Strategic Por - GuruFocus

Jul 23, 2025

Jul 23, 2025

ProKidney Corp (PROK) Completes Re-domestication to Delaware amid Kidney Therapy Advancement - MSN

Jul 23, 2025

Jul 21, 2025

11 Best High Return Penny Stocks to Buy Now - Insider Monkey

Jul 21, 2025

Jul 20, 2025

ProKidney Corp. Stock Analysis and ForecastDynamic profit expansion - Autocar Professional

Jul 20, 2025

Jul 20, 2025

JP Morgan Maintains a Neutral Stance on ProKidney Corp. (PROK) - MSN

Jul 20, 2025

Jul 20, 2025

ProKidney Corp. (PROK): Navigating Clinical Pivotality and Market Volatility in the Race for a CKD Breakthrough - AInvest

Jul 20, 2025

Jul 20, 2025

JP Morgan Maintains Neutral Stance on ProKidney Corp., Citing Extended Timeline for Key Data - AInvest

Jul 20, 2025

Jul 19, 2025

New Strong Buy Stocks for July 17th - MSN

Jul 19, 2025

Jul 18, 2025

10 Hot Penny Stocks to Invest in Now - Insider Monkey

Jul 18, 2025

Jul 18, 2025

ProKidney Shares Dip Following FDA Agreement on Rilparencel Approval Strategy - MSN

Jul 18, 2025

Jul 17, 2025

PROKIDNEY CP (PROK) Upgraded to Strong Buy: What Does It Mean for the Stock? - MSN

Jul 17, 2025

Jul 17, 2025

This Biotech Stock Jumped Over 600% in Just Days After Releasing Promising Clinical Trial Data. And Its Market Cap Is Still Only $2 Billion. But Is It a Buy? - Mitrade

Jul 17, 2025

Jul 17, 2025

Best Momentum Stocks to Buy for July 17th - Nasdaq

Jul 17, 2025

Jul 17, 2025

PROK Surges More Than 500% on Upbeat Data From Kidney Cell Therapy Study - MSN

Jul 17, 2025

Jul 17, 2025

ProKidney gains pivotal therapy advancement step with FDA - Winston-Salem Journal

Jul 17, 2025

Jul 16, 2025

ProKidney completes Delaware domestication and restructures corporate agreements By Investing.com - Investing.com Nigeria

Jul 16, 2025

Jul 16, 2025

ProKidney completes Delaware domestication and restructures corporate agreements - Investing.com

Jul 16, 2025

Jul 16, 2025

Citi Maintains ProKidney(PROK.US) With Buy Rating, Maintains Target Price $9 - 富途牛牛

Jul 16, 2025

Jul 16, 2025

Will ProKidney’s Recent Surge Last? - StocksToTrade

Jul 16, 2025

Jul 16, 2025

ProKidney’s Clinical Trials and Regulatory Developments Lead to Hold Rating Amid Uncertainty - TipRanks

Jul 16, 2025

Jul 16, 2025

ProKidney Corp. (PROK) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Jul 16, 2025

Jul 16, 2025

ProKidney’s Hold Rating: Balancing FDA Alignment and Extended Approval Timeline - TipRanks

Jul 16, 2025

Jul 16, 2025

ProKidney’s Strategic FDA Alignment and Promising Clinical Data Drive Buy Rating - TipRanks

Jul 16, 2025

Jul 15, 2025

ProKidney stock soars after FDA confirms accelerated approval pathway - Investing.com

Jul 15, 2025

Jul 15, 2025

ProKidney price target raised to $7 from $6 at Guggenheim - MSN

Jul 15, 2025

Jul 15, 2025

ProKidney’s Dramatic Shares Tumble - timothysykes.com

Jul 15, 2025